Clinical Trial

Transcranial Direct Current Stimulation for Cancer-related Cognitive Impairment in Breast Cancer Survivors

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy of transcranial direct current stimulation (tDCS) in improving cancer-related cognitive impairment (CRCI) in breast cancer survivors. Participants will be randomly assigned to receive active or sham stimulation over the prefrontal cortex. Cognitive outcomes will be assessed using standardized neuropsychological tests and self-reported measures. Functional magnetic resonance imaging (fMRI) and electroencephalography (EEG) will be used to explore neural correlates of intervention effects.
Trial Details
NCT Number NCT07083518
Lead Sponsor Anhui Medical University
Conditions Transcranial Direct Current Stimulation (tDCS), Breast Cancer Survivor, Cognitive Impairment
Enrollment 60 participants
Start Date 2025-05-29
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-24